Dinuclear and Trinuclear Zn(II) Calix[4]arene Complexes
J . Org. Chem., Vol. 64, No. 11, 1999 3905
1
1
6
59.8, 156.1, 155.7, 137.3, 135.3, 134.4, 134.3, 133.3, 131.9,
29.1, 128.8, 127.8, 122.2, 120.8, 73.4, 72.8, 69.6, 66.4, 66.2,
H), 4.08-4.02 (m, 4 H), 3.91-3.80 (m, 8 H), 3.59-3.50 (m, 8
H), 3.33 (s, 4 H), 3.23 (s, 2 H), 2.01 (s, 3 H), 1.25-1.14 (m, 12
2.7, 61.7, 46.9, 46.5, 42.5, 30.8, 15.3. FAB-MS: m/z 1042.3
H). 13C NMR (CDCl
3
, 250 MHz): δ (ppm) 158.6, 158.2, 156.6,
+
([M-Cl] , calcd 1041.5). To a solution of calix[4]arene bis-
155.9, 155.1, 137.0, 135.4, 134.5, 134.3, 131.6, 128.6, 128.3
(2×), 128.0, 122.2, 122.1, 121.6, 118.4, 73.4, 72.9, 69.7, 66.4,
66.3, 64.0, 62.2, 61.3, 42.5, 30.9, 15.3. FAB-MS: m/z 877.4 ([M
(
hydrochloride) 14 (694 mg, 0.644 mmol) in CH
NH‚HCl (1.04 g, 12.8 mmol) and K
2.8 mmol). The mixture was stirred for 16 h and concentrated
in vacuo. Saturated Na CO solution (40 mL) was added, the
aqueous layer was extracted with CH Cl
(3 × 40 mL), and
the combined organic phases were dried over K CO . Filtration
and evaporation of the solvent gave the crude product which
was purified by column chromatography (basic Al , CH Cl
MeOH, 99/1) to give 3 as a colorless oil (460 mg, 65%). H NMR
CDCl , 250 MHz): δ (ppm) 7.64 (t, 2 H, J ) 7.7 Hz), 7.36 (d,
H, J ) 7.7 Hz), 7.25 (d, 2 H, J ) 6.5 Hz), 6.88 (s, 4 H), 6.32
s, 6 H), 4.47 and 3.13 (AB q, 8 H, J ) 13.3 Hz), 4.19 (t, 4 H,
J ) 6.1 Hz), 4.01 (t, 4 H, J ) 5.3 Hz), 3.80-3.89 (m, 8 H), 3.62
s, 4 H), 3.58 (s, 4 H), 3.51 (q, 8 H, J ) 7.0 Hz), 3.38 (s, 4 H),
3
CN (60 mL)
was added Me
1
2
2
CO (1.77,
3
+
+ H] , calcd 877.5).
2
3
5-[(6-N,N-Dim eth yla m in om eth yl)p yr id in -2-yl-m eth yl)-
N -m e t h y l a m i n o m e t h y l ] -2 5 , 2 6 , 2 7 , 2 8 -t e t r a k i s ( 2 -
eth oxyeth oxy)ca lix[4]a r en e (2). This compound was syn-
thesized according to the synthesis of the bis-derivative 3. The
2
2
2
3
2
O
3
2
2
/
crude product was purified by column chromatography (basic
1
1
Al
2
O
3
, CH
2
Cl
2
) to give 2 as a colorless oil (83%). H NMR
(
2
(
3
(CDCl
3
, 250 MHz): δ (ppm) 7.63 (t, 1 H, J ) 7.7 Hz), 7.24 (d,
1 H, J ) 7.7 Hz), 7.14 (d, 1 H, J ) 7.6 Hz), 6.74-6.58 (m, 8
H), 6.43-6.37 (m, 2 H), 6.31-6.25 (m, 1 H), 4.51 and 3.15 (AB
q, 8 H, J ) 13.3 Hz), 4.49 and 3.12 (AB q, 8 H, J ) 13.2 Hz),
4.19-4.14 (m, 4 H), 4.09-4.03 (m, 4 H), 3.90-3.82 (m, 8 H),
(
2
6
1
1
4
.29 (s, 12 H), 2.18 (s, 6 H), 1.23 (t, 6 H, J ) 7.0 Hz), 1.17 (t,
3.58-3.50 (m, 10 H), 3.37 (s, 2 H), 3.21 (s, 2 H), 2.27 (s, 6 H),
1
3
13
H, J ) 7.0 Hz). C NMR (CDCl
3
, 250 MHz): δ (ppm) 159.3,
3
2.05 (s, 3 H), 1.25-1.15 (m, 12 H). C NMR (CDCl , 250
58.0, 156.4, 155.3, 136.8, 135.6, 134.0, 132.0, 129.3, 127.7,
22.2, 121.2, 73.5, 72.7, 69.6, 66.4, 66.2, 65.7, 63.0, 61.8, 45.6,
MHz): δ (ppm) 159.6, 158.0, 156.5, 155.9, 155.1, 136.6, 135.3
(2×), 134.6, 134.3, 132.3, 128.5, 128.3, 128.2, 128.0, 122.2,
122.1, 121.3, 121.0, 73.3, 72.9, 69.7, 66.4, 66.3, 65.9, 62.9, 61.6,
+
2.4, 30.8, 15.3. FAB-MS: m/z 1096.5 ([M + H] , calcd 1095.7).
+
5
-[(N -Boc-N -m e t h yl)a m in om e t h yl]-25,26,27,28-t e t -
45.7, 42.6, 31.5, 30.8, 15.3. FAB-MS, m/z 904.5 ([M + H] , calcd
r a k is(2-eth oxyeth oxy)ca lix[4]a r en e (15). This compound
904.5).
was synthesized according to the synthesis of the bis-derivative
11,23-Bis(m eth ylam in om eth yl)-26,28-di-n -pr opoxycalix-
[4]a r en e-25,27-cr ow n -3 (19). This compound was synthe-
sized according to the synthesis of the tris-derivative 8,
1
1
1, starting from formyl-tetrakis(2-ethoxyethoxy)calix[4]arene
1
6
6. The crude product was purified by column chromatog-
Cl /EtOAc, 95/5) to give 15 as a colorless oil (83%).
H NMR (CDCl , 250 MHz): δ (ppm) 6.71-6.61 (m, 6 H), 6.49
1
5
raphy (CH
2
2
starting from diformyl-di-n-propoxycalix[4]arene-crown-3 20.
The crude reaction product was pure enough for further
1
3
1
(
br s, 3 H), 6.36 (br s, 2 H), 4.50 and 3.14 (AB q, 4 H, J ) 13.3
3
modification (yield 94%). H NMR (CDCl , 400 MHz): δ (ppm)
Hz), 4.49 and 3.11 (AB q, 4 H, J ) 13.3 Hz), 4.20-4.15 (m, 4
H), 4.08-4.04 (m, 4 H), 3.98 (br s, 2 H), 3.90-3.80 (m, 8 H),
3
9
7.08 (s, 4 H), 6.17 (t, 2 H, J ) 7.6 Hz), 5.98 (d, 4 H, J ) 7.6
Hz), 4.35 and 3.16 (AB q, 8 H, J ) 13.5 Hz), 4.20 (t, 4 H, J )
4.0 Hz), 3.99 (t, 4 H, J ) 4.0 Hz), 3.76 (s, 4 H), 3.66 (t, 4 H, J
) 6.8 Hz), 2.51 (s, 6 H), 1.88-1.79 (m, 4 H), 1.57 (br s, 2 H),
.60-3.50 (m, 8 H), 2.50 and 2.31 (br s, 1 H, 2 H), 1.46 (br s,
13
H), 1.24-1.17 (m, 12 H). C NMR (CDCl , 250 MHz): δ
3
(ppm) 156.7, 155.9, 155.2, 135.4, 134.6, 134.5, 131.2, 128.3,
1.09 (t, 6 H, J ) 7.0 Hz). 13C NMR (CDCl
, 250 MHz): δ (ppm)
3
1
3
8
28.0, 127.4, 122.3, 122.1, 79.2, 73.4, 73.0, 69.7, 66.4, 66.3, 33.3,
0.9, 28.5, 15.4, 15.3. FAB-MS: m/z 856.4 ([M + H] , calcd
56.5).
157.1, 154.3, 136.4, 133.2, 132.6, 128.6, 126.6, 121.6, 76.3, 72.6,
+
+
69.7, 55.4, 35.6, 30.3, 23.0, 10.4. FAB-MS: m/z 664.3 ([M] ,
+
calcd 664.4), 634.5 ([M - NHCH
3
] , calcd 634.4).
5
-(Meth yla m in om eth yl)-25,26,27,28-tetr a k is(2-eth oxy-
11,23-Bis[((6-h yd r oxym et h yl)p yr id in -2-yl-m et h yl)-N-
m eth ylam in om eth yl]-26,28-dipr opoxycalix[4]ar en e-25,27-
cr ow n -3 (21). This compound was synthesized and purified
eth oxy)-ca lix[4]a r en e (17). This compound was synthesized
according to the synthesis of the bis-derivative 12. After
stirring in trifluoroacetic acid, the reaction mixture was
according to the synthesis and purification of the tris-deriva-
1
concentrated in vacuo to give crude 17‚3CF
which was pure enough for further modification. 1H NMR
CDCl , 250 MHz): δ (ppm) 11.68 (br s, 2 H), 8.08 (br s, 2 H),
3
COOH (99%),
tive 9 (yield 70%). H NMR (CDCl
3
, 250 MHz): δ (ppm) 7.64
(t, 2 H, J ) 7.7 Hz), 7.46 (d, 2 H, J ) 7.0 Hz), 7.18-7.12 (m,
6 H), 6.37-5.93 (m, 6 H), 4.75 (s, 4 H), 4.36 and 3.17 (AB q, 8
H, J ) 13.5 Hz), 4.19 (br s, 4 H), 4.01 (br s, 4 H), 3.75 (s, 4 H),
3.62 (s, 4 H), 2.33 (s, 6 H), 1.83 (m, 4 H), 1.09 (t, 6 H, J ) 7.4
(
3
6
4
4
3
.88-6.71 (m, 5 H), 6.47-6.39 (m, 4 H), 4.50 and 3.15 (AB q,
H, J ) 13.5 Hz), 4.48 and 3.13 (AB q, 4 H, J ) 13.3 Hz),
.25-4.19 (m, 4 H), 4.07-4.00 (m, 4 H), 3.91-3.80 (m, 8 H),
Hz). 13C NMR (CDCl
, 250 MHz): δ (ppm) 158.2, 157.7, 154.8,
3
.62-3.51 (m, 10 H), 2.18 (s, 3 H), 1.25-1.03 (m, 12 H). 13
C
137.2, 137.0, 136.8, 133.1, 130.1, 127.1, 122.1, 121.5, 118.6,
76.9, 73.1, 70.2, 64.0, 62.8, 61.9, 53.5, 42.6, 30.8, 23.5, 11.0.
NMR (CDCl , 250 MHz): δ (ppm) 156.9, 156.6, 155.8, 135.8,
3
+
1
1
3
35.6, 135.1, 134.6, 134.1, 129.6, 128.7, 128.5, 127.9, 123.5,
22.6, 121.9, 73.6, 73.5, 72.9, 69.6, 66.4, 66.3, 51.9, 31.4, 31.1,
FAB-MS: m/z 907.5 ([M + H] , calcd 907.5).
11,23-Bis[(6-N,N-d im et h yla m in om et h yl)p yr id in -2-yl-
m e t h y l)-N -m e t h y la m i n o m e t h y l]-26,28-d i p r o p o x y -
ca lix[4]a r en e-25,27-cr ow n -3 (4). This compound was syn-
thesized according to the synthesis of the tetrakis(2-ethoxy-
ethoxy) derivative 5. The crude product was purified by column
+
0.8, 30.7, 15.3. FAB-MS: m/z 756.2 ([M + H] , calcd 756.4).
The free amine 17 was obtained by extraction with CH
2
Cl
2
from saturated Na
2
CO
3
solution, followed by drying over K
2
-
1
CO
3
. H NMR (CDCl
3
, 250 MHz): δ (ppm) 6.47-6.67 (m, 11
H), 4.50 and 3.13 (AB q, 4 H, J ) 13.3 Hz), 4.48 and 3.11 (AB
q, 4 H, J ) 13.3 Hz), 4.06-4.15 (m, 8 H), 3.83-3.87 (m, 8 H),
chromatography (basic Al
2
O
3
, CH
2 2
Cl ) to give 4 as a colorless
1
oil (62%). H NMR (CDCl
3
, 400 MHz): δ (ppm) 7.67 (t, 2 H, J
3
1
1
1
3
7
.50-3.58 (m, 8 H), 3.38 (s, 2 H), 2.26 (s, 3 H), 1.40 (br s, 1 H),
) 7.7 Hz), 7.49-7.45 (m, 2 H), 7.29 (d, 2 H, J ) 7.2 Hz), 7.17
(s, 4 H), 6.13-5.94 (m, 6 H), 4.37 and 3.18 (AB q, 8 H, J )
13.7 Hz), 4.19 (br s, 4 H), 4.02 (br s, 4 H), 3.77 (s, 4 H), 3.68 (t,
1
3
.12-1.26 (m, 12 H). C NMR (CDCl , 250 MHz): δ (ppm)
3
56.4, 156.3, 155.3, 135.2, 135.1, 135.0, 134.8, 133.3, 128.3,
28.2, 128.1, 128.0, 122.2, 121.9, 73.2, 73.1, 69.7, 66.4, 55.6,
5.8, 31.5, 30.9, 15.3. FAB-MS: m/z 756.9 ([M + H] , calcd
56.4).
4 H, J ) 6.6 Hz), 3.61 (s, 8 H), 2.31 (s, 18 H), 1.96-1.82 (m, 4
+
13
H), 1.11 (t, 6 H, J ) 7.2 Hz). C NMR (CDCl , 250 MHz): δ
3
(ppm) 158.9, 157.7, 157.1, 155.8, 154.3, 136.3, 136.2, 132.6,
129.5, 126.5, 121.5, 120.7, 120.6, 76.3, 72.6, 69.7, 65.4, 62.7,
61.4, 45.1, 42.1, 30.3, 23.0, 10.4. FAB-MS: m/z 961.7 ([M +
5
-[(6-H yd r oxym et h yl)p yr id in -2-yl-m et h yl)-N-m et h yl-
a m in om e t h yl]-25,26,27,28-t e t r a k is(2-e t h oxye t h oxy)-
ca lix[4]a r en e (18). This compound was synthesized according
to the synthesis of the bis-derivative 13. The crude product
+
H] , calcd 961.6).
Sp ectr op h otom etr ic Titr a tion s. To a cuvette containing
was purified by column chromatography (CH
to give 18 as a colorless oil (65%). H NMR (CDCl
δ (ppm) 7.64 (t, 1 H, J ) 7.7 Hz), 7.11 (d, 2 H, J ) 7.7 Hz),
2
Cl
2
/MeOH, 9/1)
, 250 MHz):
3
2 mL of 50% CH CN/20 mM aqueous HEPES solution pH 7.0
1
21
3
(v/v, see kinetics), was added 8 µL of a 50 mM stock solution
of ligand 1 or 2 in EtOH (2 µL 50 mM for 3, 4, and 5). The
increase in absorbance at λ ) 266 nm at 25 °C by the ligand
6
6
.77-6.60 (m, 6 H), 6.55 (s, 2 H), 6.43-6.35 (m, 2 H), 6.30-
.24 (m, 1 H), 4.72 (s, 2 H), 4.50 and 3.15 (AB q, 8 H, J ) 13.3
3
-1
-1
3
-1
-1
1 or 2 (ꢀ266: 1, 4.0 × 10 M cm ; 2, 4.9 × 10 M cm ; 3,
3
-1
-1
3
-1
-1
3
-1
Hz), 4.48 and 3.11 (AB q, 8 H, J ) 13.2 Hz), 4.21-4.16 (m, 4
5.9 × 10 M cm ; 4, 6.0 × 10 M cm ; 5, 12 × 10 M